Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “To Determine the Bioequivalence Under Fasting Conditions”

34 trials

Showing 20 of 34 results

Early research (Phase 1)Study completedNCT04411940
What this trial is testing

Bioequivalence Study of Two Oral Haloperidol Tablets Formulations in Healthy Subjects Under Fasting Conditions

Who this might be right for
Bioequivalence
Cycle Pharmaceuticals Ltd. 32
Early research (Phase 1)Study completedNCT02402283
What this trial is testing

Study to Determine the Equivalence of Two Products Containing Metronidazole Benzoate

Who this might be right for
Healthy
Verisfield UK Ltd. Greek Branch 20
Not applicableStudy completedNCT04805827
What this trial is testing

Comparative Randomized, Single Dose, Two-way Crossover Open-label Study to Determine the Bioequivalence of Gabapentin From Nerpentin 600 mg (Test ) F.C.T (Aman Pharma ,Egypt.) and Gabapentin From Neurontin 300 mg (Referance ) H.G.C. ( Pfizer Egypt)

Who this might be right for
Healthy
Pharma Guide CRO 34
Early research (Phase 1)Study completedNCT02767310
What this trial is testing

Study to Determine the Bioequivalence of Two Products Containing Rosuvastatin (20 mg/Tablet)

Who this might be right for
Healthy
Verisfield UK Ltd. Greek Branch 49
Early research (Phase 1)Study completedNCT04476966
What this trial is testing

Bioequivalence Study of Mirabegron From Bladogra 25 mg Extended Release Tablets (Multi-Apex for Pharmaceutical Industries, Egypt) Versus Myrbetriq 25 mg Extended Release Tablets (Marketed by Astellas Pharma US, Inc, Product of Japan)

Who this might be right for
Healthy
Genuine Research Center, Egypt 29
Early research (Phase 1)Study completedNCT02006602
What this trial is testing

Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions

Who this might be right for
Hypertension
GlaxoSmithKline 16
Early research (Phase 1)Study completedNCT03432312
What this trial is testing

Single-Dose Bioequivalence Study Comparing Two 4 mg Nicotine Lozenges

Who this might be right for
Smoking Cessation
Fertin Pharma A/S 42
Early research (Phase 1)Study completedNCT00653393
What this trial is testing

Bioavailability Study of Tranylcypromine 10mg Tablets Under Fasting Conditions

Who this might be right for
To Determine the Bioavailability of Tranylcypromine
Par Pharmaceutical, Inc. 39
Early research (Phase 1)Study completedNCT02146209
What this trial is testing

Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate.

Who this might be right for
Bacterial Infections
Verisfield UK Ltd. Greek Branch 6
Early research (Phase 1)Study completedNCT05186129
What this trial is testing

Bioequivalence Study of Clopid® (Clopidogrel) 75 mg Tablet and Plavix® 75 mg Tablet After Oral Administration to Healthy Adult Subjects Under Fasting Condition

Who this might be right for
Bioequivalence
Center for Bioequivalence Studies and Clinical Research 36
Early research (Phase 1)UnknownNCT06522763
What this trial is testing

Bioequivalence Study of Sulfadoxine/Pyrimethamine 500/25 mg Dispersible Tablet

Who this might be right for
Fasting
Swiss Pharma Nigeria Limited 46
Early research (Phase 1)Study completedNCT02094924
What this trial is testing

A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323

Who this might be right for
Hypertension
GlaxoSmithKline 16
Early research (Phase 1)Study completedNCT02750709
What this trial is testing

Bioequivalence Study of Two Nitisinone Formulations Compared to Orfadin

Who this might be right for
Hereditary Tyrosinemia, Type I
Cycle Pharmaceuticals Ltd. 24
Early research (Phase 1)Study completedNCT04478448
What this trial is testing

Bioequivalence Study of Favipiravir From Flupirava 200 mg Tablet (European Egyptian Pharmaceutical Industries , Egypt) Versus Avigan 200 mg Tablets (Man. by Toyama Chemical Co., Ltd Japan)

Who this might be right for
Healthy
Genuine Research Center, Egypt 26
Early research (Phase 1)Study completedNCT02593500
What this trial is testing

Bioequivalence Study of Two Inhalation Formulations Containing Budesonide 200 µg

Who this might be right for
Allergy
Reig Jofre Group 57
Early research (Phase 1)Study completedNCT02516098
What this trial is testing

Determine the Bioequivalence of Two Formulations of Hyoscine Butylbromide.

Who this might be right for
Healthy
Boehringer Ingelheim 56
Early research (Phase 1)Study completedNCT00653315
What this trial is testing

Bioavailability Study of Tramadol/APAP Tablets Under Fasting Conditions

Who this might be right for
To Determine Bioequivalence Under Fasting Conditions
Par Pharmaceutical, Inc. 28
Early research (Phase 1)Study completedNCT04854460
What this trial is testing

Bioequivalence Study of Ivermectin From Revemact 6 mg Tablets (Man. by EVA Pharma for Horus for Pharmaceutical Industries, Egypt) and Stromectol 2*3 mg Tablets (Merck Sharp & Dohme B.V., Haarlem, The Netherlands)

Who this might be right for
Healthy
Genuine Research Center, Egypt 30
Post-approval studies (Phase 4)Study completedNCT02446496
What this trial is testing

A Bioequivalence Study of Cefadroxil Film Coated Tablets After A Single Oral Dose Administration to Healthy Subjects

Who this might be right for
Infections, Urinary Tract
GlaxoSmithKline 24
Early research (Phase 1)Study completedNCT02750345
What this trial is testing

Bioequivalence Study of Two Oral Nitisinone Formulations to Treat Hereditary Tyrosinemia (HT-1)

Who this might be right for
Hereditary Tyrosinemia, Type I
Cycle Pharmaceuticals Ltd. 24
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation